Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2020
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
BUY
Exercise of conversion of derivative security
|
Direct |
4,896
+16.29%
|
-
|
|
Feb 01
2020
|
Stephen F Fry SVP, HR & Diversity |
SELL
Payment of exercise price or tax liability
|
Direct |
5,851
-5.17%
|
$813,289
$139.64 P/Share
|
|
Feb 01
2020
|
Stephen F Fry SVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct |
13,055
+10.33%
|
-
|
|
Feb 01
2020
|
David A Ricks President, Chair, and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,089
-13.71%
|
$4,321,371
$139.64 P/Share
|
|
Feb 01
2020
|
David A Ricks President, Chair, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
69,350
+23.42%
|
-
|
|
Feb 01
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
7,299
-16.0%
|
$1,014,561
$139.64 P/Share
|
|
Feb 01
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
16,317
+26.34%
|
-
|
|
Jan 31
2020
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
5,000
-2.56%
|
-
|
|
Jan 21
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.02%
|
$1,960
$140.91 P/Share
|
|
Jan 13
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$28,495,000
$139.23 P/Share
|
|
Jan 10
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.18%
|
$28,980,000
$138.0 P/Share
|
|
Jan 09
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.1%
|
$29,920,000
$136.06 P/Share
|
|
Jan 08
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
172,650
-0.08%
|
$22,962,450
$133.6 P/Share
|
|
Jan 07
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
32,645
-0.03%
|
$4,309,140
$132.9 P/Share
|
|
Dec 20
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
19,705
-0.02%
|
$2,601,060
$132.9 P/Share
|
|
Dec 18
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.1%
|
$28,380,000
$129.14 P/Share
|
|
Dec 17
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
215,000
-0.06%
|
$26,875,000
$125.82 P/Share
|
|
Dec 16
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
89
+0.19%
|
$10,858
$122.85 P/Share
|
|
Dec 16
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
111
+0.99%
|
$13,542
$122.85 P/Share
|
|
Dec 16
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.03%
|
$2,074
$122.85 P/Share
|
|
Dec 16
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+2.7%
|
$9,882
$122.85 P/Share
|
|
Dec 09
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
10,962
-0.01%
|
$1,304,478
$119.7 P/Share
|
|
Dec 06
2019
|
Myles O'Neill SVP & Pres., Mfg. Operations |
SELL
Open market or private sale
|
Indirect |
25,000
-42.8%
|
$3,000,000
$120.0 P/Share
|
|
Dec 06
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
194,038
-0.08%
|
$23,284,560
$120.42 P/Share
|
|
Dec 06
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
4,500
-13.31%
|
$540,000
$120.0 P/Share
|
|
Dec 04
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.18%
|
$24,780,000
$118.52 P/Share
|
|
Nov 27
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
48,953
-0.04%
|
$5,727,501
$117.51 P/Share
|
|
Nov 26
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
56,729
-0.05%
|
$6,637,293
$117.81 P/Share
|
|
Nov 25
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
109,318
-0.09%
|
$12,790,206
$117.6 P/Share
|
|
Nov 22
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
251,736
-0.11%
|
$29,201,376
$116.02 P/Share
|
|
Nov 21
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
108,264
-0.09%
|
$12,450,360
$115.14 P/Share
|
|
Nov 19
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$23,575,000
$115.36 P/Share
|
|
Nov 18
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,552
+2.61%
|
$176,928
$114.07 P/Share
|
|
Nov 18
2019
|
Kathi P Seifert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+2.02%
|
$174,876
$114.07 P/Share
|
|
Nov 18
2019
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+10.72%
|
$174,876
$114.07 P/Share
|
|
Nov 18
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,653
+13.07%
|
$188,442
$114.07 P/Share
|
|
Nov 18
2019
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+21.42%
|
$174,876
$114.07 P/Share
|
|
Nov 18
2019
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+8.22%
|
$179,478
$117.07 P/Share
|
|
Nov 18
2019
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+2.33%
|
$174,876
$114.07 P/Share
|
|
Nov 18
2019
|
Michael L Eskew Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+3.56%
|
$174,876
$114.07 P/Share
|
|
Nov 18
2019
|
Carolyn R Bertozzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+23.82%
|
$174,876
$114.07 P/Share
|
|
Nov 18
2019
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+7.59%
|
$174,876
$114.07 P/Share
|
|
Nov 18
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,630
+3.38%
|
$185,820
$114.07 P/Share
|
|
Nov 18
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,687
+37.31%
|
$192,318
$114.07 P/Share
|
|
Nov 18
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
10,598
-0.01%
|
$1,208,172
$114.0 P/Share
|
|
Nov 12
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
7,981
-0.01%
|
$909,834
$114.0 P/Share
|
|
Nov 11
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
100
-0.0%
|
$11,400
$114.06 P/Share
|
|
Nov 07
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
400
-0.0%
|
$45,600
$114.37 P/Share
|
|
Nov 06
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
173,918
-0.15%
|
$19,826,652
$114.05 P/Share
|
|
Nov 04
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
7,003
-0.01%
|
$798,342
$114.04 P/Share
|